-+ 0.00%
-+ 0.00%
-+ 0.00%

Canaccord Genuity Maintains Buy on LifeStance Health Gr, Raises Price Target to $13

Benzinga·07/21/2026 11:36:58
语音播报
Canaccord Genuity analyst Richard Close maintains LifeStance Health Gr (NASDAQ:LFST) with a Buy and raises the price target from $11 to $13.